GU Cancers Symposium 2014 - Model-based investigation of the interplay between abiraterone exposure, prostate-specific antigen kinetics, and overall survival in castration-resistant prostate cancer patients - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Xu Steven Xu, Charles J. Ryan, Kim Stuyckens, Matthew R. Smith, Fred Saad, Thomas W. Griffin, Youn C. Park, Margaret K. Yu, An Vermeulen, Italo Poggesi, and Partha Nandy at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

Janssen Research & Development, Raritan, NJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Janssen Research & Development, Beerse, Belgium; Harvard Medical School and Massachusetts General Hospital, Boston, MA; University of Montréal, Montréal, QC, Canada; Janssen Research & Development, Los Angeles, CA